Safeguarding immune globulin recipients against hemolysis: what do we know and where do we go?

TransfusionVolume 55, Issue S2 p. S122-S126 SUMMARY AND FUTURE DIRECTIONS Safeguarding immune globulin recipients against hemolysis: what do we know and where do we go? Dorothy E. Scott, Corresponding Author Dorothy E. Scott Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MarylandAddress reprint requests to: Dorothy Scott, MD, OBRR/CBER/FDA, Building 52/Room 4124, 10903 New Hampshire Avenue, Silver Spring, MD 20993; e-mail: Dorothy.scott@fda.hhs.gov.Search for more papers by this authorJay S. Epstein, Jay S. Epstein Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MarylandSearch for more papers by this author Dorothy E. Scott, Corresponding Author Dorothy E. Scott Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MarylandAddress reprint requests to: Dorothy Scott, MD, OBRR/CBER/FDA, Building 52/Room 4124, 10903 New Hampshire Avenue, Silver Spring, MD 20993; e-mail: Dorothy.scott@fda.hhs.gov.Search for more papers by this authorJay S. Epstein, Jay S. Epstein Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MarylandSearch for more papers by this author First published: 14 July 2015 https://doi.org/10.1111/trf.13196Citations: 6Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume55, IssueS2Special Issue: Hemolysis Supplement Strategies to Address Hemolytic Complications of Immune Globulin InfusionsJuly 2015Pages S122-S126 RelatedInformation